Cavalry Biosciences
Engineering nature's growth factors into tissue-selective medicines for eye, muscle and nerve repair.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJan 23, 2021 (5 years old)
About Cavalry Biosciences
Explore our IGF-1 pipeline and regeneration mission.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
JV
Jan van Deursen Co-founder, AdvisorLinkedIn · source: cavalry.bio- N(Nathaniel (Ned) David Co-founder, Chairmansource: cavalry.bio
TS
Tim Stowe Founder
Companies like Cavalry Biosciences
SSerigen Mediproducts$700K Seed · Mar 2023
CClaris Bio$118M Series B+ · Jul 2026
RReCode TherapeuticsSeries B+ · Oct 2023CClutchSeries B+ · Jan 2025
EEterna Regeneratives$4M Seed · Sep 2026
NNormunity$75M Series B+ · Jan 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cavalry-biosciences (get a free API key).